Impact of the National Cervical Screening Programme in New Zealand by age: analysis of cervical cancer trends 1985–2013 in all women and in Māori women

2017 ◽  
Vol 28 (12) ◽  
pp. 1393-1404 ◽  
Author(s):  
Megan A. Smith ◽  
Simon Edwards ◽  
Karen Canfell
Keyword(s):  
Cervical Cancer ◽  
New Zealand ◽  
Screening Programme ◽  
Cervical Screening ◽  
Cancer Trends

Cervical cancer screening programme

2019 ◽  
Vol 13 (11) ◽  
pp. 526-533
Author(s):  
Ian Peate
Keyword(s):  
Cervical Cancer ◽  
Cancer Screening ◽  
Cervical Cancer Screening ◽  
Screening Programme ◽  
Cervical Screening ◽  
Signs And Symptoms ◽  
Increased Risk ◽  
Cancer Screening Programme ◽  
Cervical Cancer Screening Programme ◽  
The Uk

Screening for cervical cancer saves lives. This article provides an overview of cervical screening programmes offered by the NHS. All four countries in the UK provide a cervical cancer screening programme. Cervical screening identifies apparently healthy women who may be at increased risk of a disease or condition; this then provides an opportunity for earlier treatment or better informed decisions. In some instances, the healthcare assistant and assistant practitioner (HCA and AP) may be needed in order to provide assistance with the screening procedure, offering the woman physical and psychological support. This article offers the reader an overview of the cervix, along with a brief description of signs and symptoms of cervical cancer.

Impact of media reporting of cervical cancer in a UK celebrity on a population-based cervical screening programme

2011 ◽  
Vol 18 (4) ◽  
pp. 204-209 ◽  
Author(s):  
Georgina J Macarthur ◽  
Melissa Wright ◽  
Helen Beer ◽  
Shantini Paranjothy
Keyword(s):  
Cervical Cancer ◽  
Screening Programme ◽  
Cervical Screening ◽  
Population Based ◽  
Media Reporting

scholarly journals Rural community’s perspectives on cervical cancer screening: Report of a consensus-planning workshop

2017 ◽  
Vol 3 (s1) ◽  
pp. 73
Author(s):  
Smita Asthana ◽  
Satyanarayana Labani
Keyword(s):  
Cervical Cancer ◽  
Rural Community ◽  
Rural Women ◽  
Elderly Women ◽  
Screening Programme ◽  
Cervical Screening ◽  
Community Setting ◽  
The Elderly ◽  
Hpv Infection ◽  
Using Data

<p>The success of any screening programme depends largely on the acceptability of the community to undergo screening. This study is an attempt to explore the perspectives of rural women on screening through qualitative research,<br />using data generated in a consensus workshop for an unscreened population prior to the start of a screening programme. The study adopted a qualitative method in the form of consensus-planning workshop prior to the start of the <em>care</em>HPV screening project. Knowledge about cervical cancer and human papillomavirus (HPV) infection was found to be very low. Special efforts are needed to educate the elderly women of the family and the peers of the rural community so that the project runs successfully, as their views can influence community participation. The response by rural women in undertaking selfsamplings was good. Cervical screening is acceptable and can be implemented in a rural community setting. The success of screening programme depends on health education of the rural community.</p>

scholarly journals Cervical screening in Western Kazakhstan: Liquid-based cytology ‘Cell Scan’ versus azur-eosin staining

2019 ◽  
Vol 27 (2) ◽  
pp. 90-95 ◽  
Author(s):  
Saule Balmagambetova ◽  
Giovanni Gabutti ◽  
Arip Koyshybaev ◽  
Cecilia Acuti Martellucci ◽  
Olzhas Urazayev ◽  
...  
Keyword(s):  
Cervical Cancer ◽  
Pap Smear ◽  
Screening Programme ◽  
Cervical Screening ◽  
Staining Technique ◽  
Screening Tools ◽  
Female Population ◽  
Hpv Dna ◽  
Western Kazakhstan ◽  
Liquid Based Cytology

Objective To assess the effectiveness of the current cervical cancer screening tools in Western Kazakhstan. Methods Smears taken through (i) conventional cytology using azur-eosin staining and (ii) liquid-based cytology (LBC) ‘Cell Scan’ in the general female population and in women first diagnosed with cervical cancer were collected throughout the region. ROC-analysis with curve construction and weighted Cohen's κ calculation were applied. A total of 494 cytological pairs were collected, including 94 sets with histology findings. Results The conventional (azur-eosin staining) technique contained 0.2% non-informative material and LBC ‘Cell Scan’ had 5.9%. Area under the curve was 0.95 for the conventional technique and 0.92 for ‘Cell Scan’ ( p > 0.05). The conventional smears showed κ 0.62, sensitivity 90.4% at specificity 90.0% for CIN2+, while LBC ‘Cell Scan’ smears showed κ 0.47, sensitivity 83.3% at specificity 92.5%. Conclusions In this analysis it was not possible to prove that the LBC ‘Cell Scan’ technique was superior to its predecessor, azur-eosin staining. These findings highlight the need to modify the current screening programme according to updated international scientific evidence on effective screening design, such as the use of HPV DNA testing with Pap smear triage in women aged 30 or older. Further research, and a Health Technology Assessment, are necessary if we wish to establish a national standardized screening programme using the available technology appropriately.

Cervical Cancer Screening in Kiribati

2016 ◽  
Vol 1 (3) ◽  
Author(s):  
David Peddie
Keyword(s):  
Cervical Cancer ◽  
Cancer Screening ◽  
Cervical Cancer Screening ◽  
Screening Programme ◽  
Radiation Treatment ◽  
Cervical Screening ◽  
Invasive Cervical Cancer ◽  
Central Pacific ◽  
Cervical Cancer Screening Programme ◽  
Screening And Prevention

<p>In 1999, a cervical cancer screening programme was commenced in the central Pacific nation of Kiribati. This was in response to  the relatively high  incidence of  and mortality from  cervical cancer, although estimates are unclear, in this  country with its limited  resources. In Kiribati there are minimal surgical and  medical facilities available for treatment of invasive cervical cancer.  The  financial and social cost of   sending patients  to a remote destination, India or Taiwan, for surgical or radiation treatment  make a  strong   case for screening and prevention. A well organised screening programme, such as that of the New Zealand National Cervical Screening Programme,   can potentially prevent nine out of 10 invasive cancers.</p>

scholarly journals Screening history and FIGO-stages among Danish women with cervical cancer in 2012–2014: a register-based study

2019 ◽  
Vol 9 (1) ◽  
Author(s):  
Abir Khalil Bchtawi ◽  
Sinem Saritas ◽  
Doris Schledermann ◽  
René dePont Christensen ◽  
Kirsten Marie Jochumsen
Keyword(s):  
Cervical Cancer ◽  
Screening Programme ◽  
Treatment Options ◽  
Cervical Screening ◽  
Participation Rate ◽  
Figo Stage ◽  
Risk Of Death ◽  
Study Population ◽  
Node Metastases ◽  
Screening History

AbstractThe objective was to examine whether attendance in the mass cervical screening programme has implications for the prognosis when cervical cancer is diagnosed. We performed a retrospective analysis of all cases of cervical cancer between 1st of January 2012 and 31st of December 2014 in the Region of Southern Denmark. The cases were retrieved from the Danish National Pathology Registry, PatoBank. Odds ratios (OR) with confidence intervals (95% CI) were calculated for attendees versus non-attendees of the screening programme by using χ2-test. 216 patients were included in the study. 61.6% of the study population had not attended the screening programme. Patients who had attended the programme were characterised by disease in low stage (OR = 3.14, 95% CI; 1.66 to 5.92), treatment with surgery alone (OR = 2.63, 95% CI; 1.49 to 4.64) and a lower risk of death (OR = 0.36, 95% CI; 0.15 to 0.87). Adenocarcinomas were more often detected among attendees of the programme compared to squamous cell carcinomas (OR = 4.06, 95% CI; 2.03 to 8.14). Statistically significant results regarding relapse of cancer (OR = 0.62, 95% CI; 0.23 to 1.68, p = 0.47) and lymph node metastases (OR = 0.62, 95% CI; 0.32 to 1.21, p = 0.19) were not found. Cervical cancer detected in women who had attended the mass cervical screening programme prior to the diagnosis, was shown to have a statistically significant lower FIGO stage (p = 0.0004) and was therefore linked to less extensive treatment options. Continued focus on increasing the participation rate of the programme is of importance, as the nonattendance rate continues to be high.

Sign in / Sign up

Export Citation Format

Share Document